Barclays
RDUS

Barclays’s Radius Health, Inc. RDUS Stock Holding History

Barclays’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,900
Closed -$135K – 5745
2020
Q2 		$135K Sell
9,900
-25,400
-72% -$350K ﹤0.01% 4342
2020
Q1 		$459K Sell
35,300
-5,900
-14% -$105K ﹤0.01% 3661
2019
Q4 		$831K Buy
41,200
+20,700
+101% +$503K ﹤0.01% 3841
2019
Q3 		$528K Sell
20,500
-800
-4% -$19.6K ﹤0.01% 4204
2019
Q2 		$519K Buy
21,300
+3,000
+16% +$65.6K ﹤0.01% 4287
2019
Q1 		$365K Buy
18,300
+5,100
+39% +$93K ﹤0.01% 4363
2018
Q4 		$218K Sell
13,200
-38,100
-74% -$642K ﹤0.01% 4513
2018
Q3 		$913K Buy
51,300
+23,600
+85% +$534K ﹤0.01% 3712
2018
Q2 		$816K Sell
27,700
-22,800
-45% -$720K ﹤0.01% 3494
2018
Q1 		$1.81M Sell
50,500
-6,500
-11% -$235K ﹤0.01% 2557
2017
Q4 		$1.81M Buy
57,000
+35,900
+170% +$1.13M ﹤0.01% 2527
2017
Q3 		$813K Buy
21,100
+9,400
+80% +$369K ﹤0.01% 3188
2017
Q2 		$529K Buy
11,700
+3,400
+41% +$130K ﹤0.01% 3468
2017
Q1 		$321K Buy
8,300
+800
+11% +$33.6K ﹤0.01% 3850
2016
Q4 		$285K Buy
+7,500
New +$357K ﹤0.01% 3886

Other funds holding RDUS

RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

Barclays's RDUS Position: Q3 2022 in Review

Barclays sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 113,245 shares — an estimated $1.17M sold.

Barclays first reported a position in RDUS in Q4 2014 and held it in 31 quarters. The position peaked at $2.9M in Q3 2019. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

  • Barclays reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 113,245 Radius Health, Inc. shares in Q3 2022, an estimated $1.17M.
  • Barclays first reported a position in Radius Health, Inc. in Q4 2014 and held it in 31 quarters.
  • Barclays's Radius Health, Inc. position peaked at $2.9M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.